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Keynote message 
 
Both Positron Emission Tomography (PET) and Single Photon Emission Computed 
Tomography (SPECT, scintigraphy) are based on the use of radioactive compounds 
that, after administration, will distribute in the body and will accumulate in a variety of 
organs/tumours depending on the tracer they are bound to. In this regard, organ 
function can be visualized and insight in endocrine, metabolic and molecular 
processes of the body, can be provided. PET has superior spatial resolution 
compared to SPECT but is not yet easily accessible for veterinary use.  Classically 
scintigraphy has been used in veterinary medicine especially for thyroid disease and 
skeletal pathologies. However, several other interesting applications became 
available for a wider range of pathologies. In recent years, PET has begun to play an 
important role in the management of human cancer patients, especially to evaluate 
therapy outcome and monitor disease progression. An additional advantage is the 
possibility to label tracers with both diagnostic (imaging) and therapeutic 
(radionuclide therapy) radionuclides, allowing diagnostic screening before therapeutic 
use of the same tracer labelled with a radiotoxic compound. In this session I will 
expound on common and less common indications where both modalities play or 
may play a role in the future in veterinary medicine.  
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